12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Financial News  |  Other Financial News

Valeant Pharmaceuticals financial update

Valeant raised $300 million through the sale of 3.5 million shares at $85 to cover the...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >